| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |